Cargando…
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer
BACKGROUND: Epithelial ovarian cancer (EOC) is a lethal malignant tumor, for which new treatment options are urgently required. Lipolysis-stimulated lipoprotein receptor (LSR) is widely expressed in EOC, and it is associated with poor prognosis. In this study, we developed an antibody-drug conjugate...
Autores principales: | Kanda, Mizuki, Serada, Satoshi, Hiramatsu, Kosuke, Funauchi, Masashi, Obata, Kengo, Nakagawa, Satoshi, Ohkawara, Tomoharu, Murata, Okinori, Fujimoto, Minoru, Chiwaki, Fumiko, Sasaki, Hiroki, Ueda, Yutaka, Kimura, Tadashi, Naka, Tetsuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679668/ https://www.ncbi.nlm.nih.gov/pubmed/36413881 http://dx.doi.org/10.1016/j.neo.2022.100853 |
Ejemplares similares
-
Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer
por: Nagase, Yoshikazu, et al.
Publicado: (2022) -
Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
por: Sugase, Takahito, et al.
Publicado: (2018) -
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
por: Sugase, Takahito, et al.
Publicado: (2021) -
Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines
por: Takemoto, Norihiko, et al.
Publicado: (2015) -
Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells
por: Urushima, Hayato, et al.
Publicado: (2017)